StocksRunner logo
search
 
menu
 
  Overview  
  
  Trending  
  
  Gainers  
  
  Losers  
  
  Volume  
  
  Upgrades  
  
  Option Activity  
  
  Target Price  
  
  Technical  

 
 
Top Banner
 
 
 
Top Banner
 
 

Late Night Market Recap Stocks Making the Biggest Moves

 
  • user  Night.Owl
  •  
     
      
     
     

    Night.Owl masters market recaps, offering sharp analysis that uncovers hidden patterns and key moves. Stay ahead with Night.Owl’s expert insights.

     
 
  • like  22 Jun 2026
  •  
 
 

$SMCI Super Micro Computer led the tape with a 15.66% move on heavy volume of 122.95 million shares after GF Securities upgraded the stock. The move also placed the name among the top S&P 500 performers, with traders treating the upgrade as a fresh validation point after a volatile AI server cycle.

$GOOG Alphabet fell 5.08% on 31.54 million shares as AI competitive concerns and high-profile researcher departures weighed on sentiment. The weakness came despite continued debate around the companys enterprise AI position, Google Cloud traction, and broader hedge fund interest in AI software names.

$KLAC KLA gained 3.7% on 10.77 million shares as the AI memory and semiconductor equipment theme continued to attract institutional attention. The stock remains one of the cleaner beneficiaries of AI-driven chip complexity, with rating momentum and strong year-to-date performance keeping buyers engaged.

$LCID Lucid dropped 3.73% on 10.42 million shares after announcing a plan to cut roughly 18% of its United States workforce, while COO Marc Winterhoff exited and the role was eliminated. The market read the move as necessary cost discipline, but also as another signal that EV production demand remains under pressure.

$RGNX Regenxbio surged 16.28% on 8.98 million shares as traders responded to a fresh upside catalyst in the biotech space. The move had the look of event-driven accumulation, with volume confirming that the stock was not just drifting higher on thin liquidity.

$ABBV AbbVie rose 6.25% on 7.48 million shares after announcing a $10.9 billion acquisition of immunology-focused Apogee Therapeutics. The deal pushed AbbVie back into offensive M&A mode and signaled a clear attempt to reinforce the companys long-term immunology pipeline.

$ACA Arcosa climbed 6.67% on 4.06 million shares after CRH agreed to acquire the company in an $8.5 billion all-cash transaction. The deal gives Arcosa shareholders a clear valuation event and reinforces the market appetite for infrastructure, transmission, and building-materials assets tied to North American capital spending.

$CAT Caterpillar advanced 3.7% on 3.18 million shares and ranked among the stronger Dow components during the session. The move continued to reflect durable demand for high-quality industrial exposure, with investors still rewarding infrastructure-linked earnings visibility and capital return discipline.

$INCY Incyte gained 5.54% on 2.01 million shares after a fresh 8-K filing put the stock back on trader screens. The price reaction suggests the market was willing to reprice the name quickly, though follow-through will depend on whether volume confirms sustained institutional interest beyond the filing-driven move.

 
 
Top Banner
 
 

Unlock Exclusive Stock Insights!

Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.

Signup now for FREE and stay ahead of the market curve!


Why Join?

Find out what 5,000+ subscribers already know.

Real-time insights for informed decisions.

Limited slots available, SignUp Now!

 
Signup to Stocksrunner
 
 
 

Curated for you

Market Intelligence Feed

 
 

Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.

 
 
StocksRunner

Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future

 

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss
 

Receive Our Daily Alerts

Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

 
Our Services

Real-time stock market updates

Expert stock analysis

Investment strategies

Top stock recommendations

Trading signals and opportunities

 
About StocksRunner

Log In

Sign Up

Plans & Pricinig

Contact Us

Terms of use

Privacy Policy

 
 
 
StocksRunner

Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends

FIND US ON

StocksRunner on Facebook StocksRunner on Twitter StocksRunner on YouTube StocksRunner on stocktwits StocksRunner Rss

 

Subscribe to Our Daily Updates

Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

 
Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stocks analysis

Stocks trends

Stocks performance

Stocks analysis

Investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

 
 

Disclaimer: The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

 
 
StocksRunner logo